Dabigatran associated with increased risk of acute coronary events
Publication
, Journal Article
Kohli, P; Cannon, CP
Published in: Evidence Based Medicine
February 1, 2013
Duke Scholars
Published In
Evidence Based Medicine
DOI
EISSN
1473-6810
ISSN
1356-5524
Publication Date
February 1, 2013
Volume
18
Issue
1
Start / End Page
e9
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kohli, P., & Cannon, C. P. (2013). Dabigatran associated with increased risk of acute coronary events. Evidence Based Medicine, 18(1), e9. https://doi.org/10.1136/eb-2012-100733
Kohli, P., and C. P. Cannon. “Dabigatran associated with increased risk of acute coronary events.” Evidence Based Medicine 18, no. 1 (February 1, 2013): e9. https://doi.org/10.1136/eb-2012-100733.
Kohli P, Cannon CP. Dabigatran associated with increased risk of acute coronary events. Evidence Based Medicine. 2013 Feb 1;18(1):e9.
Kohli, P., and C. P. Cannon. “Dabigatran associated with increased risk of acute coronary events.” Evidence Based Medicine, vol. 18, no. 1, Feb. 2013, p. e9. Scopus, doi:10.1136/eb-2012-100733.
Kohli P, Cannon CP. Dabigatran associated with increased risk of acute coronary events. Evidence Based Medicine. 2013 Feb 1;18(1):e9.
Published In
Evidence Based Medicine
DOI
EISSN
1473-6810
ISSN
1356-5524
Publication Date
February 1, 2013
Volume
18
Issue
1
Start / End Page
e9
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences